Mastercard and the Medical Tourism Association join forces to revolutionize cross-border healthcare payments →

About the Provider

CELL GRAND CLINIC is a premium regenerative medicine provider located in the heart of Osaka, Japan. The clinic specializes in evidence-based regenerative therapies designed to support healthy aging and address a range of chronic and degenerative conditions through advanced cell-based medicine.

Serving both domestic and international patients, CELL GRAND CLINIC combines personalized treatment planning with modern regenerative technologies. Its approach emphasizes scientific evidence, individualized care, and strict quality standards while providing patients with a comfortable, private clinical environment throughout their treatment journey.

Mission and Care Approach

CELL GRAND CLINIC is committed to delivering regenerative medicine that is grounded in scientific evidence and tailored to each patient's individual health goals. Every treatment plan is carefully developed after evaluating the patient's condition, medical history, and desired outcomes.

The clinic follows Japan's Ministry of Health-approved regenerative medicine protocols, ensuring treatments are provided within established regulatory frameworks. Biological products are cultivated in certified GMP-compliant external Cell Processing Centers, while rigorous quality control measures, including exosome particle quantification, sterility testing, and lot-based tracking, help maintain high standards of safety and consistency.

Patients also benefit from a hospitality-focused environment featuring Japanese-modern private IV suites that prioritize comfort, privacy, and personalized attention.

Why Choose CELL GRAND CLINIC?

Personalized Regenerative Medicine

Every patient receives an individualized treatment plan based on their specific health needs and treatment objectives, allowing therapies to be tailored to each clinical situation.

Physician-Led Expertise

The clinic is led by Dr. Yuichi Wakabayashi, a U.S. board-certified regenerative medicine specialist who has managed more than 3,000 clinical cases in regenerative medicine.

Ministry of Health-Approved Protocols

Treatments are provided under approved Type II and Type III regenerative medicine plans recognized by Japan's Ministry of Health, Labour and Welfare, supporting a structured and regulated approach to regenerative care.

Advanced Quality Control

CELL GRAND CLINIC incorporates comprehensive quality assurance procedures, including exosome particle quantification, sterility testing, and lot-based product tracking for every biological therapy.

Premium Patient Experience

The clinic combines advanced medical care with a luxury healthcare environment, offering private treatment suites designed to provide comfort, privacy, and a calm atmosphere throughout each visit.

Languages Spoken

CELL GRAND CLINIC provides services in:

  • Japanese
  • English
  • Chinese

Multilingual communication allows international patients to better understand their treatment options, discuss their medical concerns confidently, and receive support throughout their healthcare journey in Japan.

Treatments Offered

Orthopedic Regenerative Treatments

These treatments are designed to support tissue healing and recovery using platelet-rich plasma therapy.

Plastic and Reconstructive Aesthetic Treatments

This regenerative treatment utilizes platelet-rich plasma to support skin rejuvenation and non-surgical aesthetic enhancement.

Stem Cell and Regenerative Medicine Treatments

These therapies reflect the clinic's focus on regenerative medicine for anti-aging, musculoskeletal disorders, neurological conditions, autoimmune diseases, metabolic disorders, chronic inflammatory diseases, and aesthetic applications.

Medical Doctor

Dr. Yuichi Wakabayashi

Dr. Yuichi Wakabayashi leads CELL GRAND CLINIC as a U.S. board-certified regenerative medicine specialist. With experience spanning more than 3,000 clinical cases, he oversees the clinic's personalized regenerative medicine programs, helping patients access evidence-based treatments developed under Japan's approved regenerative medicine protocols.

Accreditations and Certifications

CELL GRAND CLINIC maintains several important recognitions that reflect its commitment to regulated regenerative medicine and international patient care.

The clinic operates under the Approved Type II Regenerative Medicine Plan (PB5240089) authorized by the Ministry of Health, Labour and Welfare (MHLW), Japan.

It also holds the Approved Type III Regenerative Medicine Plan (PC3240034) issued by the MHLW.

Additionally, CELL GRAND CLINIC is a Full Member of Medical Excellence JAPAN (MEJ) and is recognized by MEJ as a certified facility committed to providing high-quality medical services for international patients.

Conclusion

CELL GRAND CLINIC offers a comprehensive regenerative medicine program that combines evidence-based therapies, physician-led expertise, and personalized treatment planning within a premium clinical environment in Osaka. Its focus on regulated regenerative medicine, advanced quality control, and individualized care makes it a distinctive option for patients seeking innovative approaches to anti-aging and chronic disease management.

For international patients, the clinic provides multilingual communication, Ministry of Health-approved treatment protocols, and a patient-centered experience designed to support safety, comfort, and confidence throughout the regenerative medicine journey. Individuals exploring advanced stem cell therapies and regenerative treatments in Japan may find CELL GRAND CLINIC well suited to their healthcare goals.

To request a free medical quote from CELL GRAND CLINIC please click here.

Better by MTA

ENGLISH
×

Choose your language